Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
miR-200 regulates endometrial development during early pregnancy
Patricia T. Jimenez
, Monica A. Mainigi
, R. Ann Word
, W. Le Kraus
, Carole R. Mendelson
Institute of Clinical and Translational Sciences (ICTS)
Division of Reproductive Endocrinology & Infertility
Research output
:
Contribution to journal
›
Article
›
peer-review
43
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'miR-200 regulates endometrial development during early pregnancy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Endometrial Development
100%
Early Pregnancy
100%
MicroRNA-200b
100%
Decidualization
50%
Endometrial Stromal Cells
50%
Superovulation
33%
Knockdown
16%
Molecular Mechanism
16%
Well-defined
16%
Estradiol
16%
Morphological Changes
16%
Progesterone
16%
Functional Change
16%
Endometrial Decidualization
16%
Epithelial-mesenchymal Transition
16%
Embryo Implantation
16%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
16%
Hormonal Alterations
16%
Decidual
16%
In Vitro Decidualization
16%
Predicted Targets
16%
Medicine and Dentistry
First Trimester Pregnancy
100%
microRNA 200
100%
Decidualization
83%
Stromal Cell
50%
Superovulation
33%
In Vitro
16%
Morphology
16%
Diethylstilbestrol
16%
Progesterone
16%
Mesenchymal-Epithelial Transition
16%
Nidation
16%
Transcription Factor ZEB1
16%
Biochemistry, Genetics and Molecular Biology
First Trimester Pregnancy
100%
Mir-200
100%
Decidualization
83%
Stromal Cell
50%
Mesenchymal-Epithelial Transition
16%
Morphology
16%
Nidation
16%
Transcription Factor ZEB1
16%
Estradiol
16%
Progesterone
16%
Immunology and Microbiology
First Trimester Pregnancy
100%
Decidualization
100%
Epithelial Mesenchymal Transition
20%
Morphology
20%
Nidation
20%
Transcription Factor ZEB1
20%
In Vitro
20%